Evgen Pharma PLC Company Profile (LON:EVG)

About Evgen Pharma PLC

Evgen Pharma PLC logoEvgen Pharma plc is a clinical-stage drug development company focused on cancer and neurological disease. The Company operates through the segment of development of pharmaceutical products all within the United Kingdom. Its pipeline is based on its Sulforadex technology and includes various synthetic, stabilized analogues of the naturally occurring compound sulforaphane. Its pipeline includes SFX-01: breast cancer; SFX-01: subarachnoid hemorrhage, and other programs. The objective of SFX-01 therapy is to reduce the number of cancer stem cells (CSCs) proliferating in tumors treated with anti-hormonal agents and prolong the duration of response. The objective of SFX-01 therapy (co-administered with standard-of-care nimodipine) is to reduce the vasospasm and incidence of delayed cerebral ischemia in the days following the hemorrhage. It has a preclinical SFX-01 program in multiple sclerosis and a clinical interest in prostate cancer.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: LON
  • Symbol: EVG
  • CUSIP:
Key Metrics:
  • Previous Close: $0.34
  • 50 Day Moving Average: $22.67
  • 200 Day Moving Average: $24.06
  • 52-Week Range: GBX 14.50 - GBX 35
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $19.75M
  • Outstanding Shares: 73,142,000
Additional Links:

Analyst Ratings

Consensus Ratings for Evgen Pharma PLC (LON:EVG) (?)
Ratings Breakdown: 1 Hold Rating, 1 Buy Rating
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: GBX 97

Analysts' Ratings History for Evgen Pharma PLC (LON:EVG)
Show:
DateFirmActionRatingPrice TargetDetails
2/13/2017Northland SecuritiesReiterated RatingBuyGBX 97View Rating Details
1/18/2017Beaufort SecuritiesReiterated RatingSpeculative BuyView Rating Details
1/4/2016Northland Capital PartnersReiterated RatingBuyGBX 79View Rating Details
(Data available from 2/20/2015 forward)

Earnings

Earnings History for Evgen Pharma PLC (LON:EVG)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Evgen Pharma PLC (LON:EVG)
Current Year EPS Consensus Estimate: $4.90 EPS

Dividends

Dividend History for Evgen Pharma PLC (LON:EVG)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Evgen Pharma PLC (LON:EVG)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
1/18/2016Clare,BarryInsiderBuy40,000GBX 22£8,800
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Evgen Pharma PLC (LON:EVG)
DateHeadline
directorstalkinterviews.com logoEvgen Pharma plc Services Agreement with Drug Development Consortium - DirectorsTalk Interviews (LON:EVG)
www.directorstalkinterviews.com - February 14 at 11:05 PM
proactiveinvestors.co.uk logoEvgen Pharma PLC soars on news of US patent grant - Proactive Investors UK (LON:EVG)
www.proactiveinvestors.co.uk - February 14 at 11:05 PM
proactiveinvestors.co.uk logoEvgen Pharma soars on news of US patent grant (LON:EVG)
www.proactiveinvestors.co.uk - February 14 at 6:04 PM
4-traders.com logoEvgen Pharma : Signs Services Deal For SFX-01 Drug With APTrans (LON:EVG)
www.4-traders.com - February 13 at 10:58 PM
directorstalkinterviews.com logoEvgen Pharma PLC (LON:EVG) - Northland Capital Partners Q&A with Head of Research Vadim Alexandre - DirectorsTalk Interviews (LON:EVG)
www.directorstalkinterviews.com - January 19 at 6:36 PM
directorstalkinterviews.com logoINTERVIEW: Evgen Pharma Plc Grossly undervalued say Northland Capital Partners - DirectorsTalk Interviews (LON:EVG)
www.directorstalkinterviews.com - January 19 at 3:33 AM
wsj.com logoCFO Moves: Novae Group, Evgen Pharma (LON:EVG)
blogs.wsj.com - January 18 at 3:49 AM
proactiveinvestors.co.uk logoBreakfast News - AIM Breakfast : Brady Plc, Dotdigital Group plc, Evgen Pharma, FairFX Group Plc, Global Energy ... - Proactive Investors UK (LON:EVG)
www.proactiveinvestors.co.uk - January 17 at 5:43 AM
directorstalkinterviews.com logoEvgen Pharma PLC First Patient Dosed in Breast Cancer Trial - DirectorsTalk Interviews (LON:EVG)
www.directorstalkinterviews.com - January 17 at 5:43 AM
directorstalkinterviews.com logoEvgen Pharma plc Positive DSMB Review of SAS Trial - DirectorsTalk Interviews (LON:EVG)
www.directorstalkinterviews.com - January 13 at 3:34 AM
News IconPositive DSMB Review of SAS Trial (LON:EVG)
www.pharmiweb.com - January 11 at 10:38 PM
News IconEvgen Pharma Plc EVG Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250 (LON:EVG)
www.bioportfolio.com - January 11 at 10:38 PM
News IconUK Stock Pattern of the Day: Evgen Pharma PLC (EVG) Jumps 3.48% on Dec 13 - Herald KS (LON:EVG)
heraldks.com - December 13 at 5:41 PM
directorstalkinterviews.com logoEvgen Pharma PLC Q&A: Phase II Trials of Lead Drug SFX-01 - DirectorsTalk Interviews (LON:EVG)
www.directorstalkinterviews.com - December 8 at 5:43 PM
proactiveinvestors.co.uk logoNorthland Capital Partners View on the City - Edenville Energy and Evgen Pharma - Proactive Investors UK (LON:EVG)
www.proactiveinvestors.co.uk - December 7 at 3:33 PM
directorstalkinterviews.com logoEvgen Pharma plc Significant progress made this year. - DirectorsTalk Interviews (LON:EVG)
www.directorstalkinterviews.com - December 7 at 3:33 PM
directorstalkinterviews.com logoINTERVIEW: Evgen Pharma Plc Its all looking positive - DirectorsTalk Interviews (LON:EVG)
www.directorstalkinterviews.com - December 7 at 3:33 PM
proactiveinvestors.co.uk logoBeaufort Securities Breakfast Alert: Amryt Pharmaceuticals, Berkeley Group, GlaxoSmithKline plc, Prospex Oil & Gas, Quadrise Fuels International (LON:EVG)
www.proactiveinvestors.co.uk - December 5 at 5:44 PM
morningstar.co.uk logoEvgen Pharma Eyeing Third Clinical Programme After First Half Progress (LON:EVG)
www.morningstar.co.uk - December 5 at 5:44 PM
biz.yahoo.com logoHalf Year 2017 Evgen Pharma PLC Earnings Release - Time Not Supplied (LON:EVG)
biz.yahoo.com - December 5 at 11:44 AM
directorstalkinterviews.com logoEvgen Pharma Plc Harnessing the clinical potential of sulforaphane - DirectorsTalk Interviews (LON:EVG)
www.directorstalkinterviews.com - November 30 at 10:08 PM
trustnet.com logoEvgen Pharma schedules interims (LON:EVG)
www.trustnet.com - November 17 at 4:21 PM
ft.com logoUpdate re SFX-01 Data at ECTRIMS 2016 (LON:EVG)
announce.ft.com - September 15 at 5:30 AM
proactiveinvestors.co.uk logoNorthland Capital Partners View on the City - Botswana Diamonds, Evgen Pharma plc (LON:EVG)
www.proactiveinvestors.co.uk - September 9 at 9:44 AM
morningstar.co.uk logoEvgen Pharma Shares Rise On Back Of Teaser For SFX-01 Results (LON:EVG)
www.morningstar.co.uk - September 8 at 4:50 PM
ft.com logoPresentation of SFX-01 Data at ECTRIMS 2016 (LON:EVG)
announce.ft.com - September 8 at 4:50 PM
trustnet.com logoEvgen Pharma gets FDA orphan designation (LON:EVG)
www.trustnet.com - August 25 at 9:53 AM
proactiveinvestors.co.uk logoNorthland Capital Partners View on the City - Evgen Pharma plc, James Latham plc (LON:EVG)
www.proactiveinvestors.co.uk - August 25 at 9:53 AM
reuters.com logoBRIEF-Evgen Pharma granted orphan drug designation for stabilised sulforaphane (LON:EVG)
www.reuters.com - August 24 at 4:51 PM
News IconEvgen Pharma plc Clinical Trial Approval for Phase II Study in Breast Cancer (LON:EVG)
www.bioportfolio.com - August 24 at 4:51 PM
4-traders.com logoEvgen Pharma : Says SFX-01 Granted Orphan Drug Designation In US (LON:EVG)
www.4-traders.com - August 24 at 4:51 PM
proactiveinvestors.co.uk logoNorthland Capital Partners View on the City - Evgen Pharma plc (LON:EVG)
www.proactiveinvestors.co.uk - August 17 at 5:49 AM
4-traders.com logoEvgen Pharma : Gains Approval For SFX-01 Breast Cancer Phase II Clinical Trial (LON:EVG)
www.4-traders.com - August 17 at 5:49 AM
live-pr.com logoSubarachnoid Hemorrhage Global Clinical Trials Review, H1, 2016 - New Market Report (LON:EVG)
www.live-pr.com - June 7 at 9:26 AM
4-traders.com logoEvgen Pharma : Pleased With "Significant Progress" Since AIM Listing (LON:EVG)
www.4-traders.com - June 1 at 11:11 PM
biz.yahoo.com logoFull Year 2016 Evgen Pharma PLC Earnings Release - Time Not Supplied (LON:EVG)
biz.yahoo.com - May 31 at 7:07 AM
stockhouse.com logoNotification of Preliminary Results (LON:EVG)
www.stockhouse.com - May 9 at 10:29 AM
iii.co.uk logoEVGEN PHARMA (LON:EVG)
www.iii.co.uk - May 4 at 9:52 AM
trustnet.com logoEvgen Pharma Plc to present at the SHARES Investor Evening in London on 19th May (LON:EVG)
www.trustnet.com - May 3 at 10:07 AM
thestreet.com logoOsteoarthritis Pipeline Market H1 2016 Global Review Report (LON:EVG)
www.thestreet.com - April 28 at 10:18 AM
News IconPipeline of Multiple Sclerosis Market H2 2015 Review Research (LON:EVG)
www.free-press-release-center.info - March 8 at 8:44 AM
proactiveinvestors.co.uk logoBeaufort Securities Breakfast Alert - Tertiary Minerals, Alecto Minerals, Motif Bio and others (LON:EVG)
www.proactiveinvestors.co.uk - March 3 at 8:46 AM
trustnet.com logoApproval of Phase II Clinical Trial in SAH (LON:EVG)
www.trustnet.com - March 2 at 8:47 AM
News IconOsteoarthritis H2 2015 market pipeline scrutinized in new research (LON:EVG)
www.whatech.com - February 12 at 8:17 AM
finance.yahoo.com logoOsteoarthritis Therapeutics Pipeline Review, H2 2015 - Research and Markets (LON:EVG)
finance.yahoo.com - February 9 at 4:59 PM
morningstar.co.uk logoCORRECT: DIRECTOR DEALINGS: Evgen Pharma Directors Buy 136,000 Shares (LON:EVG)
www.morningstar.co.uk - January 20 at 7:26 AM
stockmarketwire.com logoEvgen Pharma Ord 0.25p (LON:EVG)
www.stockmarketwire.com - January 19 at 7:36 AM
morningstar.co.uk logoDIRECTOR DEALINGS: Evgen Pharma Directors Bought 136,000 Shares (LON:EVG)
www.morningstar.co.uk - January 19 at 7:36 AM
trustnet.com logoEvgen Pharma PLC (EVG) (LON:EVG)
www.trustnet.com - January 19 at 7:36 AM

Social

What is Evgen Pharma PLC's stock symbol?

Evgen Pharma PLC trades on the London Stock Exchange (LON) under the ticker symbol "EVG."

Where is Evgen Pharma PLC's stock going? Where will Evgen Pharma PLC's stock price be in 2017?

2 brokers have issued 12 month target prices for Evgen Pharma PLC's shares. Their predictions range from GBX 97 to GBX 97. On average, they expect Evgen Pharma PLC's share price to reach GBX 97 in the next year.

When will Evgen Pharma PLC announce their earnings?

Evgen Pharma PLC is scheduled to release their next quarterly earnings announcement on Monday, December, 5th 2016.

How do I buy Evgen Pharma PLC stock?

Shares of Evgen Pharma PLC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

How much does a share of Evgen Pharma PLC stock cost?

One share of Evgen Pharma PLC stock can currently be purchased for approximately GBX 27.


Last Updated on 2/20/2017 by MarketBeat.com Staff